Vibrio/Leptoferm-5This page contains information on Vibrio/Leptoferm-5 for veterinary use.
The information provided typically includes the following:
- Vibrio/Leptoferm-5 Indications
- Warnings and cautions for Vibrio/Leptoferm-5
- Direction and dosage information for Vibrio/Leptoferm-5
Vibrio/Leptoferm-5This treatment applies to the following species:
Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo- Icterohaemorrhagiae-Pomona Bacterin
U.S. Vet. Lic. No.: 190
Contents: This product contains the antigens listed above.
For vaccination of healthy cows and heifers as an aid in preventing disease caused by Campylobacter fetus, Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae, and L. pomona.
Directions For Use
Shake well. Aseptically administer 2 mL intramuscularly. In accordance with Beef Quality Assurance guidelines, this product should be administered in the muscular region of the neck. Administer two 2-mL doses 2-4 weeks apart to all breeding-age cows and heifers 30-60 days before exposure or being added to the breeding herd. Annual revaccination with a single dose is recommended.
Precaution(s): Store at 2°-7°C. Do not freeze. Use entire contents when first opened. Occasional hypersensitivity reactions may occur up to 18 hours postvaccination. While this event appears to be rare overall, dairy cattle may be affected more frequently than other cattle.
Warning(s): Do not vaccinate within 21 days before slaughter.
For veterinary use only.
Presentation: 10 dose (20 mL) and 50 dose (100 mL) vials.
NAC No.: 36900013
333 PORTAGE STREET, KALAMAZOO, MI, 49007
|Every effort has been made to ensure the accuracy of the Vibrio/Leptoferm-5 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06